Understanding the USP Chapter 1224 for Transfer of Analytical Methods

This webinar will explain about understanding of USP and FDA requirement , FDA Guidance on Analytical methods transfer, Responsibilities of the transferring and receiving laboratory, and also explain how to conduct and document method transfer.

Dr. Ludwig Huber
Instructor:
Dr. Ludwig Huber
Date:
Thursday, July 25, 2019
Time:
10:00 AM PDT | 01:00 PM EDT
Duration:
75 Minutes

More Trainings by this Expert   Product Id : 502608

Price Details
$150 Live
$290 Corporate Live
$190 Recorded
$390 Corporate Recorded
Combo Offers
Live + Recorded
$289 $340 Live + Recorded
Corporate (Live + Recorded)
$599 $680 Corporate
(Live + Recorded)
Price Detail Options
Overview:

When validated methods are transferred between laboratories and sites, their validated state should be maintained to ensure the same reliable results in the receiving laboratory.

So far there has not been an official guidance on what exactly is expected to maintain 'the validated state'. Now the USP has published a proposal for a general chapter <1224>. Also the FDA has released an official guidance on how to conduct and document method transfer. The USP chapter will become official with USP 35. Now it is a good time to learn how to conduct and document method transfer. This webinar will give a good understanding of USP and FDA requirement and provide recommendations and tools for effective implementation.

For easy implementation, Attendees will receive

  • SOP: Transfer of Analytical Methods
  • Checklist: Transfer of Analytical Methods and Procedures
  • Master Plan template and examples: Transfer of Analytical Methods and procedures

Areas Covered in the Session:
  • FDA and International expectations for method transfer
  • Examples of FDA warning letters and how to avoid them
  • The FDA Guidance on method transfer
  • The proposal for a USP chapter <1224>: history, status, future
  • Four approaches for analytical method transfer and testing
  • Responsibilities of the transferring and receiving laboratory
  • Developing a transfer plan and a pre-approval protocol
  • Conducting comparative studies
  • Criteria and approaches for risk based testing: what, when, how much?
  • The importance and selection of acceptance criteria
  • Dealing with technology transfer: validation requirements, regulatory notification
  • Method transfer from standard HPLC to UHPLC
  • Most likely failures during method transfer
  • Handling deviations from documented acceptance criteria
  • Criteria for transfer waiver (omission of formal transfer)

Who Will Benefit:
  • Analysts
  • Lab Supervisors and Managers
  • QA Managers and Personnel
  • Consultants
  • Teachers


Speaker Profile
Ludwig Huber Ph.D., is the director and editor of Labcompliance the global online resource for validation and compliance. He is the author of the books "Validation and Qualification in Analytical Laboratories" and "Validation of Computerized Analytical and Networked Systems, Informa Healthcare". He has given more than 300 presentations mainly on GLP/GMP, 21 CFR Part 11 and Validation around the world. For more information, please visit Dr. Huber’s website www.ludwig-huber.com




Your Recently Viewed Webinars

Payment Methods

Contact Us

NetZealous LLC,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.

Information

  Refund Policy
  +1-800-447-9407
  Fax: 302 288 6884
  support@compliance4All.com